Efficacy News and Research

RSS
MDD with subthreshold hypomania ‘should be merged with bipolar II’

MDD with subthreshold hypomania ‘should be merged with bipolar II’

Enrollment complete in Euthymics’ amitifadine phase 2b/3a trial for major depressive disorder

Enrollment complete in Euthymics’ amitifadine phase 2b/3a trial for major depressive disorder

Transplanted neural stem cells able to produce new myelin in children with PMD

Transplanted neural stem cells able to produce new myelin in children with PMD

Final results from Covidien’s DEFINITIVE LE study on peripheral arterial disease

Final results from Covidien’s DEFINITIVE LE study on peripheral arterial disease

Six-gene signature can predict survival in men with aggressive prostate cancer

Six-gene signature can predict survival in men with aggressive prostate cancer

Ischemic preconditioning tested in stroke patients

Ischemic preconditioning tested in stroke patients

Zero out of TEN for fecal incontinence treatment

Zero out of TEN for fecal incontinence treatment

MDD with subthreshold hypomania ‘should be merged with bipolar II’

MDD with subthreshold hypomania ‘should be merged with bipolar II’

PARP-1 plays a major role in controlling AR function in prostate cancer patients

PARP-1 plays a major role in controlling AR function in prostate cancer patients

QRxPharma, Paladin execute licensing agreement for MOXDUO

QRxPharma, Paladin execute licensing agreement for MOXDUO

Johns Hopkins joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

Johns Hopkins joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

New data from Genzyme's AUBAGIO and LEMTRADA clinical trials to be presented at ECTRIMS

New data from Genzyme's AUBAGIO and LEMTRADA clinical trials to be presented at ECTRIMS

Recombinant protein may treat male factor fertility

Recombinant protein may treat male factor fertility

FDA task force to examine solutions to improve, speed antibiotic research

FDA task force to examine solutions to improve, speed antibiotic research

New neuroprotective agent for stroke patients potentially found

New neuroprotective agent for stroke patients potentially found

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

NCI awards Cellerant SBIR contract to develop Megakaryocyte Progenitor Cell therapy for thrombocytopenia

NCI awards Cellerant SBIR contract to develop Megakaryocyte Progenitor Cell therapy for thrombocytopenia

Trevena reports completion of TRV027 Phase 2a study in advanced heart failure patients

Trevena reports completion of TRV027 Phase 2a study in advanced heart failure patients

Progenra’s  USP7 and USP47 exert non-overlapping anticancer cell effects

Progenra’s USP7 and USP47 exert non-overlapping anticancer cell effects

Study demonstrates efficacy of genotyping technology in identifying source of clinic infection outbreak

Study demonstrates efficacy of genotyping technology in identifying source of clinic infection outbreak

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.